An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma

Aberrant expression of microRNAs may affect tumorigenesis and progression by regulating their target genes. This study aimed to construct a risk model for predicting the prognosis of patients with lung adenocarcinoma (LUAD) based on differentially expressed microRNA-regulated target genes. The miRNA...

Full description

Bibliographic Details
Main Authors: Ning Zhou, Min Zhou, Ning Ding, Qinglin Li, Guangming Ren
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.726742/full
_version_ 1818824089855328256
author Ning Zhou
Min Zhou
Ning Ding
Qinglin Li
Guangming Ren
author_facet Ning Zhou
Min Zhou
Ning Ding
Qinglin Li
Guangming Ren
author_sort Ning Zhou
collection DOAJ
description Aberrant expression of microRNAs may affect tumorigenesis and progression by regulating their target genes. This study aimed to construct a risk model for predicting the prognosis of patients with lung adenocarcinoma (LUAD) based on differentially expressed microRNA-regulated target genes. The miRNA sequencing data, RNA sequencing data, and patients’ LUAD clinical data were downloaded from the The Cancer Genome Atlas (TCGA) database. Differentially expressed miRNAs and genes were screened out by combining differential analysis with LASSO regression analysis to further screen out miRNAs associated with patients’ prognosis, and target gene prediction was performed for these miRNAs using a target gene database. Overlapping gene screening was performed for target genes and differentially expressed genes. LASSO regression analysis and survival analysis were then used to identify key genes. Risk score equations for prognostic models were established using multifactorial COX regression analysis to construct survival prognostic models, and the accuracy of the models was evaluated using subject working characteristic curves. The groups were divided into high- and low-risk groups according to the median risk score, and the correlation with the clinicopathological characteristics of the patients was observed. A total of 123 up-regulated miRNAs and 22 down-regulated miRNAs were obtained in this study. Five prognosis-related miRNAs were screened using LASSO regression analysis and Kaplan-Meier method validation, and their target genes were screened with the overlap of differentially expressed genes before multifactorial COX analysis finally resulted in an 11-gene risk model for predicting patient prognosis. The area under the ROC curve proved that the model has high accuracy. The 11-gene risk-prediction model constructed in this study may be an effective predictor of prognosis.
first_indexed 2024-12-18T23:50:20Z
format Article
id doaj.art-7ac2c0808a674b408f0b0edd70261789
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-18T23:50:20Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-7ac2c0808a674b408f0b0edd702617892022-12-21T20:46:59ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-11-011110.3389/fonc.2021.726742726742An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung AdenocarcinomaNing ZhouMin ZhouNing DingQinglin LiGuangming RenAberrant expression of microRNAs may affect tumorigenesis and progression by regulating their target genes. This study aimed to construct a risk model for predicting the prognosis of patients with lung adenocarcinoma (LUAD) based on differentially expressed microRNA-regulated target genes. The miRNA sequencing data, RNA sequencing data, and patients’ LUAD clinical data were downloaded from the The Cancer Genome Atlas (TCGA) database. Differentially expressed miRNAs and genes were screened out by combining differential analysis with LASSO regression analysis to further screen out miRNAs associated with patients’ prognosis, and target gene prediction was performed for these miRNAs using a target gene database. Overlapping gene screening was performed for target genes and differentially expressed genes. LASSO regression analysis and survival analysis were then used to identify key genes. Risk score equations for prognostic models were established using multifactorial COX regression analysis to construct survival prognostic models, and the accuracy of the models was evaluated using subject working characteristic curves. The groups were divided into high- and low-risk groups according to the median risk score, and the correlation with the clinicopathological characteristics of the patients was observed. A total of 123 up-regulated miRNAs and 22 down-regulated miRNAs were obtained in this study. Five prognosis-related miRNAs were screened using LASSO regression analysis and Kaplan-Meier method validation, and their target genes were screened with the overlap of differentially expressed genes before multifactorial COX analysis finally resulted in an 11-gene risk model for predicting patient prognosis. The area under the ROC curve proved that the model has high accuracy. The 11-gene risk-prediction model constructed in this study may be an effective predictor of prognosis.https://www.frontiersin.org/articles/10.3389/fonc.2021.726742/fulllung adenocarcinomamiRNAprognosisLASSOrisk score
spellingShingle Ning Zhou
Min Zhou
Ning Ding
Qinglin Li
Guangming Ren
An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma
Frontiers in Oncology
lung adenocarcinoma
miRNA
prognosis
LASSO
risk score
title An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma
title_full An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma
title_fullStr An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma
title_full_unstemmed An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma
title_short An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma
title_sort 11 gene signature risk prediction model based on prognosis related mirnas and their target genes in lung adenocarcinoma
topic lung adenocarcinoma
miRNA
prognosis
LASSO
risk score
url https://www.frontiersin.org/articles/10.3389/fonc.2021.726742/full
work_keys_str_mv AT ningzhou an11genesignatureriskpredictionmodelbasedonprognosisrelatedmirnasandtheirtargetgenesinlungadenocarcinoma
AT minzhou an11genesignatureriskpredictionmodelbasedonprognosisrelatedmirnasandtheirtargetgenesinlungadenocarcinoma
AT ningding an11genesignatureriskpredictionmodelbasedonprognosisrelatedmirnasandtheirtargetgenesinlungadenocarcinoma
AT qinglinli an11genesignatureriskpredictionmodelbasedonprognosisrelatedmirnasandtheirtargetgenesinlungadenocarcinoma
AT guangmingren an11genesignatureriskpredictionmodelbasedonprognosisrelatedmirnasandtheirtargetgenesinlungadenocarcinoma
AT ningzhou 11genesignatureriskpredictionmodelbasedonprognosisrelatedmirnasandtheirtargetgenesinlungadenocarcinoma
AT minzhou 11genesignatureriskpredictionmodelbasedonprognosisrelatedmirnasandtheirtargetgenesinlungadenocarcinoma
AT ningding 11genesignatureriskpredictionmodelbasedonprognosisrelatedmirnasandtheirtargetgenesinlungadenocarcinoma
AT qinglinli 11genesignatureriskpredictionmodelbasedonprognosisrelatedmirnasandtheirtargetgenesinlungadenocarcinoma
AT guangmingren 11genesignatureriskpredictionmodelbasedonprognosisrelatedmirnasandtheirtargetgenesinlungadenocarcinoma